Management of Neutrophilia, Monocytosis, and Lymphopenia

Initial Diagnostic Approach

The European Hematology Association recommends excluding hematologic malignancy, specifically chronic myelomonocytic leukemia (CMML), when persistent monocytosis (>1×10⁹/L) is present with neutrophilia, as this triad can represent clonal myeloid disease rather than reactive changes 1
A complete patient history should be obtained, targeting infectious diseases, solid tumors, and chronic inflammatory conditions that could cause reactive monocytosis, as recommended by the European Hematology Association 1
The American Society of Hematology suggests performing a thorough physical examination, focusing on spleen size assessment and evaluation for cutaneous lesions, which are common in CMML 1

The Infectious Diseases Society of America states that an absolute lymphocyte count <700/mm³ serves as a surrogate marker for neutropenia risk and indicates increased susceptibility to opportunistic infections 2
Lymphopenia increases infection risk independent of neutrophil count, particularly for viral and fungal pathogens, according to the National Comprehensive Cancer Network 2
The Centers for Disease Control and Prevention recommend that if lymphopenia is profound, CD4 count should be assessed—CD4 <200 cells/mm³ requires pneumocystis prophylaxis 3, 4

The American Society of Clinical Oncology suggests starting levofloxacin or ciprofloxacin 500 mg orally daily if absolute lymphocyte count remains <700/mm³ or if neutropenia develops (ANC <500/mm³) 3, 4
The Infectious Diseases Society of America recommends initiating trimethoprim-sulfamethoxazole orally three times weekly (or alternative if sulfa allergy) for lymphopenia with CD4 <200 cells/mm³ 3, 4
The National Comprehensive Cancer Network advises starting acyclovir 400 mg or valacyclovir 500 mg orally twice daily to prevent herpes simplex and varicella-zoster reactivation in setting of lymphopenia 3, 4
The European Conference on Infections in Leukaemia recommends fluconazole 400 mg orally daily if neutropenia develops (ANC <1000/mm³) or if lymphopenia is severe 3, 4

The American Society of Hematology suggests weekly complete blood count with differential until counts stabilize or underlying diagnosis is established, although this fact is also mentioned in Praxis Medical Insights, a similar recommendation is found in 3, 4
The European Hematology Association recommends daily assessment for fever, signs of infection, and mucositis, as well as monitoring for hepatosplenomegaly progression, new lymphadenopathy, or constitutional symptoms suggesting malignancy 1, 4